| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 12.5 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 25.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline with Tween-80 | 50.0 mg/kg/injection | 127.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 26.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 26.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 112.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 40.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 43.2 mg/kg/injection | 125.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 113.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 114.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 126.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 60.0 mg/kg/injection | 110.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 72.0 mg/kg/injection | 117.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 90.0 mg/kg/injection | 107.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 90.0 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 60; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 120.0 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | alkali diluted with saline | 200.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 02/08 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 15.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 15.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 20.0 mg/kg/injection | 100.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 30.0 mg/kg/injection | 104.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 30.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 40.0 mg/kg/injection | 100.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 60.0 mg/kg/injection | 133.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 60.0 mg/kg/injection | 136.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 80.0 mg/kg/injection | 104.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 120.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | saline | 160.0 mg/kg/injection | 90.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | water | 20.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | water | 40.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | median survival time | water | 60.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |